TARA 241220 2.50C (TARA241220C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

TARA241220C2500

Watchlist

0.35
+0.15+75.00%

15min DelayClose Nov 25 16:00 ET

0.35High0.35Low

Intraday

5D
Daily

News

Express News | HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target
BenzingaNov 14 06:55 ET
Oppenheimer Maintains Protara Therapeutics(TARA.US) With Buy Rating, Cuts Target Price to $25
Moomoo NewsNov 13 08:31 ET · Ratings
Oppenheimer Sticks to Their Buy Rating for Protara Therapeutics (TARA)
TipRanksNov 13 08:08 ET · Ratings
Protara Therapeutics | 8-K: Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
SECNov 12 11:57 ET
Protara Therapeutics | 10-Q: Q3 2024 Earnings Report
SECNov 12 09:42 ET · Announcements
Protara Therapeutics Reports Q3 EPS (50c), Consensus (52c)
TipRanksNov 12 08:11 ET

Comments

Jaguar8

Nov 15 18:04

NEWS

$Protara Therapeutics (TARA.US)$
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology
Protara Therapeutics (Nasdaq: TARA) announced upcoming presentation of interim data from its Phase 2 ADVANCED-2 trial of TARA-002 for non-muscle invasive bladder cancer (NMIBC) at the Society of Urologic Oncology Annual Meeting. The presentation will include safety data and new efficacy...

Stock_Drift

Nov 15 17:13

$Protara Therapeutics (TARA.US)$

Jaguar8

Sep 9 07:04

NEWS

$Protara Therapeutics (TARA.US)$
Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
• 78% of patients dependent on parenteral support were choline deficient, with 63% of these patients demonstrating liver dysfunction, including steatosis, cholestasis, and hepatobiliary injury
• IV Choline Chloride could fill a significant unmet medical need for th...

Seraphicall

Jun 4 00:55

Going for a good one?

$Protara Therapeutics (TARA.US)$
soon?